123 related articles for article (PubMed ID: 38335300)
1. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
3. A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue.
Bowman BM; Montgomery SA; Schrank TP; Simon JM; Ptacek TS; Tamir TY; Mulvaney KM; Weir SJ; Nguyen TT; Murphy RM; Makowski L; Hayes DN; Chen XL; Randell SH; Weissman BE; Major MB
J Pathol; 2020 Oct; 252(2):125-137. PubMed ID: 32619021
[TBL] [Abstract][Full Text] [Related]
4. NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
Guan L; Nambiar DK; Cao H; Viswanathan V; Kwok S; Hui AB; Hou Y; Hildebrand R; von Eyben R; Holmes BJ; Zhao J; Kong CS; Wamsley N; Zhang W; Major MB; Seol SW; Sunwoo JB; Hayes DN; Diehn M; Le QT
Cancer Res; 2023 Mar; 83(6):861-874. PubMed ID: 36652552
[TBL] [Abstract][Full Text] [Related]
5. TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
Hamad SH; Montgomery SA; Simon JM; Bowman BM; Spainhower KB; Murphy RM; Knudsen ES; Fenton SE; Randell SH; Holt JR; Hayes DN; Witkiewicz AK; Oliver TG; Major MB; Weissman BE
Oncogene; 2022 Jun; 41(25):3423-3432. PubMed ID: 35577980
[TBL] [Abstract][Full Text] [Related]
6.
García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH
Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233
[TBL] [Abstract][Full Text] [Related]
7. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
8. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
[TBL] [Abstract][Full Text] [Related]
9. Specific Deletion of p16
Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A
Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051
[TBL] [Abstract][Full Text] [Related]
10. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
11. Impact of HPV infection on oral squamous cell carcinoma.
Götz C; Drecoll E; Straub M; Bissinger O; Wolff KD; Kolk A
Oncotarget; 2016 Nov; 7(47):76704-76712. PubMed ID: 27732948
[TBL] [Abstract][Full Text] [Related]
12. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y; Xie T; Wang B; Wang R; Cai Y; Yuan B; Gleber-Netto FO; Tian X; Rodriguez-Rosario AE; Osman AA; Wang J; Pickering CR; Ren X; Sikora AG; Myers JN; Rangel R
Commun Biol; 2022 Jul; 5(1):757. PubMed ID: 35902768
[TBL] [Abstract][Full Text] [Related]
14. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
15. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
16. Involvement of the p53-p16/RB pathway control mechanism in early-stage carcinogenesis in head and neck squamous cell carcinoma.
Mori T
Pathol Int; 2022 Dec; 72(12):577-588. PubMed ID: 36218243
[TBL] [Abstract][Full Text] [Related]
17. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.
Moral M; Segrelles C; Lara MF; Martínez-Cruz AB; Lorz C; Santos M; García-Escudero R; Lu J; Kiguchi K; Buitrago A; Costa C; Saiz C; Rodriguez-Peralto JL; Martinez-Tello FJ; Rodriguez-Pinilla M; Sanchez-Cespedes M; Garín M; Grande T; Bravo A; DiGiovanni J; Paramio JM
Cancer Res; 2009 Feb; 69(3):1099-108. PubMed ID: 19176372
[TBL] [Abstract][Full Text] [Related]
18. Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H).
Li Z; Gonzalez CL; Wang B; Zhang Y; Mejia O; Katsonis P; Lichtarge O; Myers JN; El-Naggar AK; Caulin C
J Pathol; 2016 Oct; 240(2):224-34. PubMed ID: 27447534
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma.
Kim HS; Chung WB; Hong SH; Kim JA; Na SY; Jang HJ; Sohn YK; Kim JW
Mol Cells; 2000 Oct; 10(5):557-65. PubMed ID: 11101148
[TBL] [Abstract][Full Text] [Related]
20. HPV acting on E-cadherin, p53 and p16: literature review.
Ottria L; Candotto V; Cura F; Baggi L; Arcuri C; Nardone M; Gaudio RM; Gatto R; Spadari F; Carinci F
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):73-79. PubMed ID: 29460521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
